tiprankstipranks
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (HK:2591)
:2591
Hong Kong Market
2591
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
RESEARCH TOOLSreports
Want to see HK:2591 full AI Analyst Report?

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (2591) Financial Statements

0 Followers

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Financial Overview

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H's market cap is currently HK$6.48B. The company's EPS TTM is HK$; its P/E ratio is -14.14; Guangzhou Innogen Pharmaceutical Group Co Ltd Class H is scheduled to report earnings on ―, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23
Income Statement
Total Revenue¥ 128.11M¥ 0.00¥ 0.00
Gross Profit¥ 104.43M¥ 0.00¥ 0.00
Operating Income¥ -333.90M¥ 0.00¥ 0.00
EBITDA¥ -324.30M¥ -156.89M¥ -711.42M
Net Income¥ -332.53M¥ -174.69M¥ -733.38M
Balance Sheet
Cash & Short-Term Investments¥ 1.21B¥ 796.88M¥ 945.34M
Total Assets¥ 1.57B¥ 934.80M¥ 1.11B
Total Debt¥ 166.33M¥ 9.90M¥ 46.59M
Net Debt¥ -803.41M¥ -516.64M¥ -361.08M
Total Liabilities¥ 517.84M¥ 138.33M¥ 400.24M
Stockholders' Equity¥ 1.05B¥ 796.47M¥ 705.13M
Cash Flow
Free Cash Flow¥ -317.57M¥ -166.95M¥ -176.79M
Operating Cash Flow¥ -295.54M¥ -162.62M¥ -164.60M
Investing Cash Flow¥ 22.63M¥ 275.95M¥ -157.21M
Financing Cash Flow¥ 722.37M¥ 254.84M¥ 351.71M
Currency in CNY

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Earnings and Revenue History

Income Statement >

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Debt to Assets

Balance Sheet >

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Cash Flow

Cash Flow >

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Forecast EPS vs Actual EPS

Earnings >